PMID- 34315495 OWN - NLM STAT- MEDLINE DCOM- 20220328 LR - 20221207 IS - 1476-511X (Electronic) IS - 1476-511X (Linking) VI - 20 IP - 1 DP - 2021 Jul 27 TI - High lipoprotein(a) concentrations are associated with lower type 2 diabetes risk in the Chinese Han population: a large retrospective cohort study. PG - 76 LID - 10.1186/s12944-021-01504-x [doi] LID - 76 AB - BACKGROUND: Lipoprotein (a) [Lp(a)] is a proven independent risk factor for coronary heart disease. It is also associated with type 2 diabetes mellitus (T2DM). However, the correlation between Lp(a) and T2DM has not been clearly elucidated. METHODS: This was a retrospective cohort study involving 9248 T2DM patients and 18,496 control individuals (1:2 matched). Patients were randomly selected from among inpatients in the Second Affiliated Hospital of Nanchang University between 2006 and 2017. Clinical characteristics were compared between the two groups. Spearman rank-order correlation coefficients were used to evaluate the strength and direction of monotonic associations of serum Lp(a) with other metabolic risk factors. Binary logistic regression analysis was used to establish the correlation between Lp(a) levels and T2DM risk. RESULTS: The median Lp(a) concentration was lower in T2DM patients than in controls (16.42 vs. 16.88 mg/dL). Based on four quartiles of Lp(a) levels, there was a decrease in T2DM risk from 33.7% (Q1) to 31.96% (Q4) (P for trend < 0.0001). Then, Lp(a) levels > 28.72 mg/dL (Q4) were associated with a significantly lower T2DM risk in the unadjusted model [0.924 (0.861, 0.992), P = 0.030]. Similar results were obtained in adjusted models 1 [Q4, 0.925 (0.862, 0.993), P = 0.031] and 2 [Q4, 0.919 (0.854, 0.990), P = 0.026]. Furthermore, in the stratified analysis, Q4 of Lp(a) was associated with a significantly lower T2DM risk among men [0.813 (0.734, 0.900), P < 0.001] and those age > 60 years [0.819 (0.737, 0.910), P < 0.001]. In contrast, the low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) did not impact these correlations between Lp(a) and diabetes. CONCLUSIONS: There is an inverse association between Lp(a) levels and T2DM risk in the Chinese population. Male patients, especially those aged more than 60 years with Lp(a) > 28.72 mg/dL, are low-risk T2DM individuals, regardless of LDL-C levels and CHD status. CI - (c) 2021. The Author(s). FAU - Fu, Qingan AU - Fu Q AD - Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. FAU - Hu, Lijuan AU - Hu L AD - Department of Nursing, Science and Technology College of Jiangxi University of Traditional Chinese Medicine, Nanchang, China. FAU - Xu, Yuan AU - Xu Y AD - Department of Medical Big Data Center, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. FAU - Yi, Yingping AU - Yi Y AD - Department of Medical Big Data Center, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. FAU - Jiang, Long AU - Jiang L AUID- ORCID: 0000-0002-1506-7385 AD - Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. skyiadx@hotmail.com. LA - eng GR - No. 81700792/National Natural Science Foundation for Young Scientists of China/ GR - 2018YFC1312902/National Key R&D Program of China/ GR - No. 2018ACB21035/Natural Science Foundation of Jiangxi Province for Distinguished Young Scholars of China/ GR - No. 20171BAB215004/Natural Science Foundation of Jiangxi Province (CN)/ GR - No. PY201821/Nanchang University youth teacher training fund/ GR - 20193ABC03A043/the 03-special project of jiangxi science and technology department/ PT - Journal Article DEP - 20210727 PL - England TA - Lipids Health Dis JT - Lipids in health and disease JID - 101147696 RN - 0 (Lipoprotein(a)) SB - IM MH - Asian People/statistics & numerical data MH - Case-Control Studies MH - China/epidemiology MH - Diabetes Mellitus, Type 2/epidemiology/*etiology MH - Female MH - Humans MH - Hyperlipoproteinemias/blood/*complications MH - Lipoprotein(a)/*blood MH - Male MH - Middle Aged MH - Retrospective Studies MH - Risk Factors PMC - PMC8317300 COIS- All authors have given permission to submit, and there are no conflicts of interests to report. The Authors declare that there is no conflict of interest. EDAT- 2021/07/29 06:00 MHDA- 2022/03/29 06:00 PMCR- 2021/07/27 CRDT- 2021/07/28 05:36 PHST- 2021/04/15 00:00 [received] PHST- 2021/07/15 00:00 [accepted] PHST- 2021/07/28 05:36 [entrez] PHST- 2021/07/29 06:00 [pubmed] PHST- 2022/03/29 06:00 [medline] PHST- 2021/07/27 00:00 [pmc-release] AID - 10.1186/s12944-021-01504-x [pii] AID - 1504 [pii] AID - 10.1186/s12944-021-01504-x [doi] PST - epublish SO - Lipids Health Dis. 2021 Jul 27;20(1):76. doi: 10.1186/s12944-021-01504-x.